Vol. 89, No. 4, 2012
Issue release date: December 2012
Free Access
Urol Int 2012;89:380–386
Add to my selection

Outcomes of Ureteroscopy for Stone Disease in Pregnancy: Results from a Systematic Review of the Literature

Laing K.A.a · Lam T.B.L.a · McClinton S.a · Cohen N.P.a · Traxer O.c · Somani B.K.b
aDepartment of Urology, Aberdeen Royal Infirmary, Aberdeen, and bDepartment of Urology, University Hospitals Southampton NHS Trust, Southampton, UK; cDepartment of Urology, Tenon University Hospital, Paris, France
email Corresponding Author


 goto top of outline Key Words

  • Pregnancy
  • Stones
  • Lithotripsy
  • Laser
  • Urolithiasis

 goto top of outline Abstract

Introduction: Our aim was to evaluate the clinical efficacy and safety of ureteroscopy as a primary treatment for pregnant women with symptomatic ureteric stones who have failed conservative management. Materials and Methods: A systematic review of the literature from January 1990 to June 2011 was performed, including all English language articles. Outcome measures were clinical efficacy, in terms of stone clearance and need for additional procedures, and safety in terms of complications. Results: A total of 239 abstracts were screened and 15 studies were identified reporting on 116 procedures. The surgical methods of stone management employed were stone extraction with basket only (n = 55, 47%), laser fragmentation (n = 27, 23%; holmium, n = 20, pulse dye, n = 7), impact lithotripsy (n = 21, 18%), ureteroscopic lithotripsy (n = 6, 5%) and a combination of methods (n = 6, 5%). A post-operative stent was inserted in 64 of 116 procedures (55%). Complete stone clearance was seen in 100 of the 116 procedures (86%). There were 2 major complications (1 ureteral perforation and 1 case of premature uterine contraction) and 7 minor complications (5 urinary tract infections and 2 cases of post-operative pain). Conclusion: This review suggests that stone clearance using ureteroscopy is a relatively safe option in pregnancy with a high success rate.

Copyright © 2012 S. Karger AG, Basel

goto top of outline Introduction

Urolithiasis can complicate up to 1 in 200 pregnancies [1,2,3]. It is the second most common cause of abdominal pain in pregnant women after urinary tract infection (UTI) [1,2,3] and is the commonest non-obstetric reason for admission to hospital during pregnancy. Within this group, 80–90% of pregnant women are in the 2nd or 3rd trimester of their pregnancy. Multiparous women are also more commonly affected [4,5,6,7].

During pregnancy, there is physiologic dilatation of the collecting systems, allowing for migration of renal stones into the ureter, leading to obstruction and/or pain. This could explain the reason for the observation that during pregnancy, stones are twice as likely to be found in the ureter than in the renal pelvis or calyxes. Physiological hydronephrosis caused by the enlarging uterus is present in 90% of pregnancies by the 3rd trimester [8,9,10,11]. This can make it more difficult to diagnose intramural obstruction during pregnancy. However, hydronephrosis due to pregnancy does not usually extend below the pelvic brim, and hence dilatation below this level is more likely to be due to an intraluminal cause such as ureteric stones.

Renal colic, infection and obstruction are a source of significant morbidity and potentially mortality to mother and child. The main risks are pre-term labour, which can occur in up to 40% of women [8], pre-term delivery and premature rupture of membranes.

The management of urolithiasis in pregnancy is mainly conservative in the first instance, with spontaneous stone passage in approximately 70–80% of patients [9]. Expectant management includes hydration and analgesia. The use of oral calcium channel blockers, α-blockers and corticosteroids remains unproven in pregnant women, predominately due to safety concerns within this population. Approximately 20–30% of pregnant women will require therapeutic intervention. Indications for operative intervention are renal colic refractory to conservative treatment, sepsis and renal tract obstruction in a solitary kidney [3,10,11,12,13,14].

The European Association of Urology guidelines [15] state that pregnant women with renal colic who have failed conservative management should be treated with temporising measures such as a stent or nephrostomy. Ureteroscopy (URS) can be considered, but only in specialist centres.

Temporising measures such as ureteric stenting or nephrostomy insertion can be performed under local anaesthetic with ultrasound scanning or minimal radiographic screening; however, during pregnancy there is accelerated encrustation and plugging which may result in frequent replacement of stents or nephrostomy tubes. With continued advancements in endoscopic technology and endourological techniques, URS has become less invasive and less traumatic such that it may be considered as first-line treatment in the management of ureteric stones in pregnancy.

We conducted a systematic review to assess the relative merits and harms of URS in the treatment of urolithiasis in pregnancy.


goto top of outline Materials and Methods

goto top of outline Search Strategy

This systematic review was performed according to the Cochrane diagnostic accuracy review guidelines. The search strategy was conducted to find relevant studies from MEDLINE (1966 to June 2011), EMBASE (1980 to June 2011), the Cochrane Central Register of Controlled Trials (in The Cochrane Library, Issue 1, 2011), CINAHL (1872 to June 2011), Google Scholar and individual urological journals.

Terms used included the following: ‘ureteroscopy’, ‘pregnancy’, ‘calculi’, ‘stones’, ‘laser’ and ‘urolithiasis’. Mesh phrases included the following: (‘Ureteroscopy’ [Mesh]) AND ‘Pregnancy’ [Mesh], (‘Calculi’ [Mesh]) AND ‘Ureteroscopy’ [Mesh], (‘Pregnancy’ [Mesh]) AND ‘Stones’ [Mesh], (‘Pregnancy’ [Mesh]) AND (‘Lasers’ [Mesh] OR ‘Laser Therapy’ [Mesh]), ((‘Lasers’ [Mesh]) AND ‘Calculi’ [Mesh]) AND ((‘Pregnancy’ [Mesh]), and (‘Ureteroscopy’ [Mesh]) AND (‘Calculi’ [Mesh])). Reference lists of selected papers and abstracts from the annual meetings of the American Urological Association, European Association of Urology and the World Congress of Endourology were also searched for further eligible studies. Finally, ongoing trials were searched using ClinicalTrials.gov. The search was performed by B.K.S. and K.A.L. and was limited to the English language. References of searched papers were evaluated for potential inclusion, and the more recently published version was included if the publication was duplicated. Authors of the included studies were contacted wherever data were not available or not clear. Disagreement between the reviewers was resolved by discussion. If agreement between the two reviewers could not be reached, a third author (T.B.L.L.) was consulted for arbitration and consensus.

The participants included pregnant women in all stages of pregnancy, who were 16 or over and who had failed conservative management for ureteric stones. The reasons for failure are outlined in the methodology section. They underwent URS ± lithotripsy/stone extraction under local, regional or general anaesthetic. Comparisons were made between immediate versus delayed stone treatment. Immediate treatment included URS ± lithotripsy ± stenting and URS + stone extraction. Delayed treatment included stent + delayed URS, stent + delayed shock wave lithotripsy (SWL), nephrostomy + delayed URS and nephrostomy + delayed SWL. The outcomes measured were safety and adverse effects, graded using the Clavien criteria. Efficacy was defined by the stone clearance rate and the need for additional procedures such as ureteric stenting. Process and recovery outcomes were measured by length of hospital stay, analgesic requirements and quality of life measures.

goto top of outline Criteria for Inclusion

All studies published between January 1990 and June 2011 were eligible for evaluation. To satisfy the criteria for inclusion it was necessary that the study report on URS in a population of pregnant women of at least 3 patients and that the method of stone extraction, success rate and urological and obstetric complications be documented. Complications were graded in accordance with the Clavien criteria wherever possible or as defined by the study authors.

goto top of outline Quality Assessment of Included Studies

Risk of bias assessment and assessment of quality of evidence were planned, but since only retrospective case series were identified, formal risk of bias and quality assessments were not performed.

goto top of outline Data Extraction

Studies relevant to the ureteroscopic management of pregnant patients were included. The following variables were extracted from each study: period of the study; country of origin of the study; stone size and location; patient demographics such as age, gestation and type of anaesthetic; number of URS performed; method of anaesthesia; method of stone extraction; ureteric stent insertion; use of fluoroscopy; stone-free outcome, and urological, obstetric and other complications.


goto top of outline Results

A total of 15 reports of URS in pregnant women were identified in the literature search (fig. 1). All of these were retrospective case series. These reports included 116 pregnant women undergoing URS for ureteric stone disease (tables 1, 2). The mean age was 28 years (range 16–41); the majority of patients were in the 2nd or 3rd trimester of pregnancy. Most patients underwent the procedure under local anaesthetic or spinal/epidural anaesthesia. Ten procedures were performed under local anaesthetic, 46 under epidural/spinal anaesthesia and 44 under general anaesthetic, and the type of anaesthesia was not documented in 6 cases.

Table 1. Summary of study information and patient demographics in the studies included

Table 2. Management and outcomes of patients in the studies included

Fig. 1. Outcomes of the literature search.

Stone location was documented in 10 studies (86 patients). The stone location was in the proximal, middle and distal ureter in 31, 9 and 46 patients, respectively. Stone size was only documented in 7 studies (range: 3– 11 mm for distal stones and 5–16 mm for proximal stones). The stone procedure was performed by rigid URS (n = 62, 53%), semi-rigid URS (n = 47, 45%), flexible URS (n = 3, 3%) or mini-ureteroscope (n = 4, 3%). During the procedure, fluoroscopy was used in 23 patients (20%). There were a number of methods used for stone extraction. The commonest method was basket extraction, which was used in 55 patients (47%). Laser and lithoclasts were popular for stone fragmentation, being used in 27 (23%) and 21 patients (18%), respectively. In a small proportion of patients, ultrasonic lithotripsy (USL) and a combination of techniques were required for stone extraction. The stone was extracted successfully in 100 patients (86%). In 6 patients, there was displacement of the stone into the renal pelvis necessitating SWL post partum. Sixty-four patients (55%) had a ureteric stent placed at the end of the procedure. The majority of procedures were performed without incident. There was 1 reported incidence of premature uterine contraction (Clavien criteria grade II), 5 UTIs (Clavien criteria grade I), 1 ureteral perforation (Clavien criteria grade III) and 2 cases of prolonged admission due to pain (Clavien criteria grade I). There were no maternal or foetal deaths reported.


goto top of outline Discussion

Retrograde stone extraction during pregnancy is becoming more common. The findings of this systematic review suggest that it is a procedure with high efficacy, with 86% of cases achieving complete stone clearance. Fluoroscopy and radiation exposure should be limited during pregnancy due to the risks to the foetus, and this was only required in 23 patients (20%). A number of techniques were used for stone extraction, including USL, basket extraction and lithoclast. A ureteric stent was placed in 55% of patients, which is disappointing as although they can allow adequate drainage of an obstructed system they are more prone to encrustation due to the increased concentration of calcium and urate in urine during pregnancy [13]. This encrustation can necessitate frequent stent changes, which can be as often as every 4–6 weeks. These additional procedures are associated with morbidity such as UTI, stent migration and pain, which can have adverse effects on the pregnancy. Nephrostomy for obstruction secondary to urolithiasis in pregnancy [14] has also been described but is subject to similar complications and is not well tolerated, with a third of patients requiring removal of the nephrostomy tube due to pain, fever or drain obstruction [14]. Both are only temporary measures and do not provide definitive management of the obstructing calculus. To their advantage, ureteric stent insertion and nephrostomy placement can be successfully performed under local anaesthetic, thus reducing the potential risks of a general anaesthetic for the pregnant women. However, many of the URS procedures reported in this systematic review were performed under local or regional anaesthetic.

Technological advancements in endourology such as the development of the semi-rigid or flexible ureteroscope could be one of the reasons why URS is increasingly being used in pregnancy. There have also been improvements in the design of baskets used for retrieval, and the availability of laser, SWL and USL enables the atraumatic fragmentation of stones.

Complications were infrequent in pregnant women undergoing URS, with only 2 patients (1.6%) suffering a major complication. There was no mortality reported either for mothers or unborn children.

The review had some inherent limitations. Firstly, the paucity of well-designed randomised trials or comparative prospective studies assessing the role of URS in pregnant women was a clear limitation. Virtually all studies were retrospective case series without a control arm, and this inevitably introduces selection bias, as various confounding variables such as stone size, stone location and type of stones were not accounted for. This limits the evidence base somewhat. However, given the relative rarity of urolithiasis in pregnancy, especially complicated cases requiring surgical intervention, coupled with the high efficacy of URS and the lack of therapeutic alternatives, it may not be feasible nor pragmatic to conduct comparative studies on such women, let alone randomised studies. However, future studies should be prospective at the very least, with clearly specified objectives, an assessment of confounding variables such as stone size and location, and the measurement of clinically meaningful outcome measures, including quality of life outcomes.

Secondly, it was also unclear in the majority of studies how patients were selected, as there were no inclusion criteria in the majority of studies. This limitation may affect the external validity of the review findings. Thirdly, performance bias may also have been an issue, as it was not clear in the majority of studies what was the grade of the surgeon performing the URS. URS and in situ lithotripsy or stone retrieval is a complex procedure with a relatively long learning curve, and hence the surgical outcomes of experts and trainee surgeons are likely to be different. Finally, publication bias is also possible, as unfavourable results are less likely to have been reported or published. This assertion is supported by the apparent discrepancy between the relatively low number of patients in this review (n = 116 only) and the reported incidence of urolithiasis of up to 1 in 200 pregnancies, especially with 20–30% of patients failing expectant management. This observation suggests it is probable that more women are undergoing URS during pregnancy than is being reported, and our review was limited as only case series were included.

With these limitations in mind, the evidence base in regard to level 1–3 evidence for the role of URS in the treatment of urolithiasis in pregnancy is poor, and hence further well-designed, prospective studies which take into account selection bias, performance bias and the issue of confounding are required.


goto top of outline Conclusion

In spite of the various limitations, the findings from this systematic review suggest that URS appears to be a safe procedure during pregnancy, which can be performed under local or regional anaesthesia without the need of fluoroscopy. As such, it may be considered as a first-line treatment of ureteric calculi in those who have failed expectant management. To optimise outcomes in terms of efficacy and safety, URS in pregnancy should ideally be performed by experts in high-volume centres.

 goto top of outline References
  1. Gorton E, Whitfield H: Renal calculi in pregnancy. Br J Urol 1997;80(suppl 1):4–9.

    External Resources

  2. Rodriguez PN, Klein AS: Management of urolithiasis in pregnancy. Surg Gynecol Obstet 1988;166:103–106.
  3. Drago JR, Rohner TJ, Chez RA: Management of urinary calculi in pregnancy. Urology 1982;20:578–581.
  4. Maikranz P, Coe FL, Parks JH, Lindheimer MD: Nephrolithiasis and gestation. Baillieres Clin Obstet Gynaecol 1987;1:909–919.
  5. Maikranz P, Lindheimer M, Coe F: Nephrolithiasis in pregnancy. Baillieres Clin Obstet Gynaecol 1994;8:375–386.
  6. Loughlin KR: Management of urologic problems during pregnancy. Urology 1994;44:159–169.
  7. Biyani CS, Joyce AD: Urolithiasis in pregnancy. I. Pathophysiology, fetal considerations, and diagnosis. BJU Int 2002;89:811–818.
  8. Kroovand RL: Stones in pregnancy; in Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds): Kidney Stones: Medical and Surgical Management. Philadelphia, Lippincott-Raven, 1996, pp 1059–1064.
  9. Lu Z, Dong Z, Ding H, Wang H, Ma B, Wang Z: Tamsulosin for ureteral stones: a systematic review and meta-analysis of a randomized controlled trial. Urol Int 2012;89:107–115.
  10. Hendricks SK, Ross SO, Krieger JN: An algorithm for diagnosis and therapy of management and complications of urolithiasis during pregnancy. Surg Gynecol Obstet 1991;172:49–54.
  11. Swartz MA, Lydon-Rochelle MT, Simmon D, Wright JL, Porter MP: Admission for nephrolithiasis in pregnancy and risk of adverse birth outcomes. Obstet Gynecol 2007;109:1099–1104.
  12. Boridy IC, Maklad N, Sandler CM: Suspected urolithiasis in pregnant women: imaging algorithm and literature review. AJR Am J Roentgenol 1996;167:869–875.
  13. McAleer SJ, Loughlin KR: Nephrolithasis and pregnancy. Curr Opin Urol 2004;14:123–127.
  14. Khoo L, Anson K, Patel U: Success and short-term complication rates of percutaneous nephrostomy during pregnancy. J Vasc Interv Radiol 2004;15:1469–1473.
  15. Türk C, Knoll T, Petrik A, et al: Guidelines on Urolithiasis. European Association of Urology, 2011.
  16. Scarpa RM, De Lisa A, Usai E: Diagnosis and treatment of ureteral calculi during pregnancy with rigid ureteroscopes. J Urol 1996;155:875–877.
  17. Carringer M, Swartz R, Johansson JE: Management of ureteric calculi during pregnancy by ureteroscopy and laser lithotripsy. Br J Urol 1996;77:17–20.
  18. Ulvik NM, Bakke A, Høisaeter PA: Ureteroscopy in pregnancy. J Urol 1995;154:1660–1663.
  19. Juan YS, Wu WJ, Chuang SM, Wang CJ, Shen JT, Long CY, Huang CH: Management of symptomatic urolithiasis during pregnancy. Kaohsiung J Med Sci 2007;23:241–246.
  20. Akpinar H, Tüfek I, Alici B, Kural AR: Ureteroscopy and holmium laser lithotripsy in pregnancy: stents must be used postoperatively. J Endourol 2006;20:107–110.
  21. Yang CH, Chan PH, La SK, Chang HC, Chiu B, Lin HM, Sheu MH: Urolithiasis in pregnancy. J Chin Med Assoc 2004;67:625–628.

    External Resources

  22. Lemos GC, El Hayek OR, Apezzato M: Rigid ureteroscopy for diagnosis and treatment of ureteral calculi during pregnancy. Int Braz J Urol 2002;28:311–315; discussion 316.

    External Resources

  23. Lifshitz DA, Lingeman JE: Ureteroscopy as a first-line intervention for ureteral calculi in pregnancy. J Endourol 2002;16:19–22.
  24. Watterson JD, Girvan AR, Beiko DT, Nott L, Wollin TA, Razvi H, Denstedt JD: Ureteroscopy and holmium:YAG laser lithotripsy: an emerging definitive management strategy for symptomatic ureteral calculi in pregnancy. Urology 2002;60:383–387.
  25. Shokeir AA, Mutabagani H: Rigid ureteroscopy in pregnant women. Br J Urol 1998; 81:678–681.
  26. Parulkar BG, Hopkins TB, Wollin MR, Howard PJ Jr, Lal A: Renal colic during pregnancy: a case for conservative treatment. J Urol 1998;159:365–368.
  27. Denstedt JD, Razvi H: Management of urinary calculi during pregnancy. J Urol 1992; 148:1072–1074; discussion 1074–1075.
  28. Rana AM, Aquil S, Khawaja AM: Semirigid ureteroscopy and pneumatic lithotripsy as definitive management of obstructive ureteral calculi during pregnancy. Urology 2009;73:964–967.
  29. Travassos M, Amselem I, Filho NS, Miguel M, Sakai A, Consolmagno H, Nogueira M, Fugita O: Ureteroscopy in pregnant women for ureteral stone. J Endourol 2009;23:405–407.
  30. Cocuzza M, Colombo JR Jr, Lopes RI, Piovesan AC, Borges Mesquita JL, Srougi M: Use of inverted fluoroscope’s C-arm during endoscopic treatment of urinary tract obstruction in pregnancy: a practicable solution to cut radiation. Urology 2010;75:1505–1508.

 goto top of outline Author Contacts

Bhaskar K. Somani
University Hospitals Southampton NHS Trust
Southampton SO16 6YD (UK)
E-Mail bhaskarsomani@yahoo.com

 goto top of outline Article Information

Published online: November 10, 2012
Number of Print Pages : 7
Number of Figures : 1, Number of Tables : 2, Number of References : 30

 goto top of outline Publication Details

Urologia Internationalis

Vol. 89, No. 4, Year 2012 (Cover Date: December 2012)

Journal Editor: Wirth M.P. (Dresden), Porena M. (Perugia), Hakenberg O.W. (Rostock), Castro-Diaz D. (Santa Cruz de Tenerife), Wullich B. (Erlangen)
ISSN: 0042-1138 (Print), eISSN: 1423-0399 (Online)

For additional information: http://www.karger.com/UIN

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.